{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:09:12Z","timestamp":1787738952992,"version":"build-2784847793"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T00:00:00Z","timestamp":1563580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008021","name":"Bristol-Myers Squibb Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014571","name":"Alvin J. Siteman Cancer Center","doi-asserted-by":"publisher","award":["CA091842"],"award-info":[{"award-number":["CA091842"]}],"id":[{"id":"10.13039\/100014571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["30 CA91842"],"award-info":[{"award-number":["30 CA91842"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 TR002345"],"award-info":[{"award-number":["1 TR002345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ebiom.2019.07.053","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T07:53:27Z","timestamp":1564127607000},"page":"170-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Novel cell adhesion\/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma"],"prefix":"10.1016","volume":"46","author":[{"given":"Jared M.","family":"Andrews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Musiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Mehta-Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8832-3661","authenticated-orcid":false,"given":"Jacqueline E.","family":"Payton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"205","key":"10.1016\/j.ebiom.2019.07.053_bb0005","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome): Part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers","volume":"70","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0010","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0015","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.1996.03890350051009","article-title":"Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis","volume":"132","author":"Kim","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0020","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ajh.24876","article-title":"Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management","volume":"92","author":"Wilcox","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0025","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ajh.23756","article-title":"Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management","volume":"89","author":"Wilcox","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s40257-018-0380-7","article-title":"Current status of HDAC inhibitors in cutaneous T-cell lymphoma","volume":"19","author":"Lopez","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.18632\/genesandcancer.65","article-title":"Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy","volume":"6","author":"Haery","year":"2015","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0040","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome \u2014 biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0045","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1200\/JCO.2008.21.6150","article-title":"Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma","volume":"27","author":"Piekarz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0050","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1200\/JCO.2010.28.9066","article-title":"Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma","volume":"28","author":"Whittaker","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2141.2009.07954.x","article-title":"Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma","volume":"148","author":"Bates","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2017.05.008","article-title":"Chromatin accessibility landscape of cutaneous T Cell lymphoma and dynamic response to HDAC inhibitors","volume":"32","author":"Qu","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0065","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1021\/mp200329f","article-title":"Histone deacetylase inhibitors: emerging mechanisms of resistance","volume":"8","author":"Robey","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-12-394387-3.00002-1","article-title":"Mechanisms of resistance to histone deacetylase inhibitors","volume":"116","author":"Lee","year":"2012","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2016.00099","article-title":"An efficient electroporation protocol for the genetic modification of mammalian cells","volume":"4","author":"Chicaybam","year":"2017","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0080","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1038\/ncomms7033","article-title":"An ultra-low-input native ChIP-seq protocol for genome-wide profiling of rare cell populations","volume":"6","author":"Brind'Amour","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Consortium","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0095","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2012.101","article-title":"Identifying ChIP-seq enrichment using MACS","volume":"7","author":"Feng","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0105","doi-asserted-by":"crossref","first-page":"W160","DOI":"10.1093\/nar\/gkw257","article-title":"deepTools2: a next generation web server for deep-sequencing data analysis","volume":"44","author":"Ram\u00edrez","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0110","doi-asserted-by":"crossref","first-page":"D762","DOI":"10.1093\/nar\/gkx1020","article-title":"The UCSC genome browser database: 2018 update","volume":"46","author":"Casper","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2014.00075","article-title":"Impact of artifact removal on ChIP quality metrics in ChIP-seq and ChIP-exo data","volume":"5","author":"Carroll","year":"2014","journal-title":"Front Genet"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature10730","article-title":"Differential oestrogen receptor binding is associated with clinical outcome in breast cancer","volume":"481","author":"Ross-Innes","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0125","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","article-title":"ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization","volume":"31","author":"Yu","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0140","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0145","doi-asserted-by":"crossref","DOI":"10.21105\/joss.00885","article-title":"Genotify: fast, lightweight gene lookup and summarization","volume":"3","author":"Andrews","year":"2018","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/bty405","article-title":"SoS notebook: an interactive multi-language data analysis environment","author":"Peng","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0155","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0160","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00109-006-0097-6","article-title":"Quantitative real-time RT-PCR data analysis: current concepts and the novel \u201cgene expression's CTdifference\u201d formula","volume":"84","author":"Schefe","year":"2006","journal-title":"J Mol Med"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0165","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2016.05.018","article-title":"The colonic crypt protects stem cells from microbiota-derived metabolites","volume":"165","author":"Kaiko","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0170","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1476-5381.2010.01188.x","article-title":"The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells","volume":"162","author":"Tiffon","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0175","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2326-6066.CIR-17-0270","article-title":"Primary T cells from cutaneous T-cell lymphoma skin explants display an exhausted immune checkpoint profile","volume":"6","author":"Querfeld","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0180","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1042\/BST20120249","article-title":"Rab25 in cancer: a brief update","volume":"40","author":"Mitra","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccell.2018.05.012","article-title":"Apoptotic cell-derived extracellular vesicles promote malignancy of glioblastoma via intercellular transfer of splicing factors","volume":"34","author":"Pavlyukov","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semcancer.2016.05.001","article-title":"NF-\u03baB deregulation in Hodgkin lymphoma","volume":"39","author":"Weniger","year":"2016","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0195","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00277-014-2116-y","article-title":"Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy","volume":"93","author":"Carbone","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0200","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beha.2016.09.002","article-title":"MALT lymphoma: genetic abnormalities, immunological stimulation and molecular mechanism","volume":"30","author":"Du","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0210","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/bjd.12578","article-title":"Lessons learned from gene expression profiling of cutaneous T-cell lymphoma","volume":"169","author":"Dulmage","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0215","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.18632\/oncotarget.13810","article-title":"Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma","volume":"8","author":"Abe","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0220","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11864-016-0410-8","article-title":"Genetics of cutaneous T cell lymphoma: from bench to bedside","volume":"17","author":"Damsky","year":"2016","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0235","doi-asserted-by":"crossref","first-page":"30346","DOI":"10.1074\/jbc.M702965200","article-title":"Polysialylated neuropilin-2 is expressed on the surface of human dendritic cells and modulates dendritic cell-T lymphocyte interactions","volume":"282","author":"Curreli","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0240","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4049\/jimmunol.180.3.1662","article-title":"The soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the collagen\/LAIR-1 inhibitory immune interaction","volume":"180","author":"Lebbink","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0245","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.immuni.2014.12.021","article-title":"Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma","volume":"42","author":"Koues","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.03018","article-title":"Potential role of CXCR4 targeting in the context of radiotherapy and immunotherapy of cancer","volume":"9","author":"Eckert","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0255","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.imlet.2009.09.014","article-title":"LAIR and collagens in immune regulation","volume":"128","author":"Meyaard","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0260","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1182\/blood-2006-12-061507","article-title":"Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome","volume":"110","author":"Shin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0265","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1038\/jid.2015.139","article-title":"Aurora kinase a is upregulated in cutaneous T-cell lymphoma and represents a potential therapeutic target","volume":"135","author":"Humme","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0270","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1182\/blood-2010-07-294819","article-title":"Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL\/CD95L transcription","volume":"117","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0275","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1074-7613(00)80530-0","article-title":"LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes","volume":"7","author":"Meyaard","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00585","article-title":"The impact of HLA class I-specific killer cell immunoglobulin-like receptors on antibody-dependent natural killer cell-mediated cytotoxicity and organ allograft rejection","volume":"7","author":"Rajalingam","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0285","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/jhg.2015.64","article-title":"Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations","volume":"60","author":"Hirayasu","year":"2015","journal-title":"J Hum Genet"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063282","article-title":"Serum LAIR-2 is increased in autoimmune thyroid diseases","volume":"8","author":"Simone","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0295","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","article-title":"Targeting the cancer epigenome for therapy","volume":"17","author":"Jones","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0300","first-page":"1","article-title":"Targeted epigenetic repression of a lymphoma oncogene by sequence-specific histone modifiers induces apoptosis in DLBCL","volume":"0","author":"Luo","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0305","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.celrep.2017.02.067","article-title":"Cis-regulatory circuits regulating NEK6 kinase overexpression in transformed B cells are super-enhancer independent","volume":"18","author":"Huang","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0310","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019505","article-title":"Epigenetic determinants of cancer","volume":"8","author":"Baylin","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0315","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1182\/blood-2017-06-792150","article-title":"Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients","volume":"130","author":"Cyrenne","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0320","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1182\/blood-2008-05-156851","article-title":"Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors","volume":"113","author":"Whitecross","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0325","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1158\/1078-0432.CCR-10-0032","article-title":"The combination of a histone deacetylase inhibitor with the Bcl-2 homology domain-3 mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy","volume":"16","author":"Wei","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0330","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.exphem.2007.12.008","article-title":"Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma","volume":"36","author":"Yazbeck","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0335","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1054\/bjoc.2000.1327","article-title":"P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228","volume":"83","author":"Sandor","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0340","doi-asserted-by":"crossref","first-page":"13563","DOI":"10.18632\/oncotarget.6916","article-title":"Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma","volume":"7","author":"Ikeda","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0345","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1182\/blood-2017-03-770982","article-title":"TCR-CXCR4 signaling stabilizes cytokine mRNA transcripts via a PREX1-Rac1 pathway: implications for CTCL","volume":"130","author":"Kremer","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0350","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","article-title":"Skin homing of S\u00e9zary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV","volume":"107","author":"Narducci","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0355","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5114\/pdia.2015.48034","article-title":"Expression of CXCR4 and CXCL12 and their correlations to the cell proliferation and angiogenesis in mycosis fungoides","volume":"32","author":"Maj","year":"2015","journal-title":"Adv Dermatol Allergol Dermatol Alergol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0360","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2013-09-527739","article-title":"MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma","volume":"123","author":"Ito","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0365","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3389\/fimmu.2018.01821","article-title":"Targeting B cell maturation antigen (BCMA) in multiple myeloma: potential uses of BCMA-based immunotherapy","volume":"9","author":"Cho","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0370","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1084\/jem.20052554","article-title":"Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1","volume":"203","author":"Lebbink","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012174","article-title":"Efficient inhibition of collagen-induced platelet activation and adhesion by LAIR-2, a soluble Ig-like receptor family member","volume":"5","author":"Lenting","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0380","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1002\/art.30612","article-title":"Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) and soluble LAIR-1 in rheumatoid arthritis: LAIR-2 is a more efficient antagonist of the LAIR-1\u2013collagen inhibitory interaction than is soluble LAIR-1","volume":"63","author":"Nordkamp","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ebiom.2019.07.053_bb0385","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124233","article-title":"Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma","volume":"4","author":"Vieyra-Garcia","year":"2019","journal-title":"JCI Insight"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419304955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419304955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:53:52Z","timestamp":1762455232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419304955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":77,"alternative-id":["S2352396419304955"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.07.053","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel cell adhesion\/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.07.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}